灼伤后肥厚性疤痕的临床症状以及需要药物干预的瘙痒和疼痛风险因素分析。

IF 2.5 3区 医学 Q2 DERMATOLOGY
Bo Chen, Qing Jia, Jing Huang, YaoHui Gu
{"title":"灼伤后肥厚性疤痕的临床症状以及需要药物干预的瘙痒和疼痛风险因素分析。","authors":"Bo Chen, Qing Jia, Jing Huang, YaoHui Gu","doi":"10.1097/DSS.0000000000004516","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pruritus and pain symptoms secondary to hypertrophic scars (HTSs) are associated with multiple factors, with age, body mass index (BMI), and scar thickness being the main risk factors (RFs).</p><p><strong>Objective: </strong>This study mainly discusses the clinical symptoms associated with postburn HTSs and analyzes RFs for itching and pain requiring pharmacological intervention.</p><p><strong>Materials and methods: </strong>All clinical data of 93 patients with postburn HTSs who visited the Burn Department of Shanghai Seventh People's Hospital between January 1, 2021 and January 1, 2023 were collected and analyzed retrospectively. Referring to the University of North Carolina \"4P\" Scar Scale, patients were rated as either \"with\" or \"without\" according to whether they had \"scar itching symptoms requiring pharmacological intervention.\"</p><p><strong>Results: </strong>Smoking, third-degree burns, unused silicone drugs, and total burn surface area 30% to 50% were independent RFs for requiring pharmacological intervention for postburn scar pruritus (odds ratio [OR] = 2.998, 3.924, 3.588, and 5.965, p < .05). Age, increased BMI, greater scar thickness, and duration of hyperplasia not more than 1 year significantly increased the risk of scar pain requiring medical intervention (OR = 1.626, 2.441, 20.830, 11.646, and 11.136, p < .05).</p><p><strong>Conclusion: </strong>The clinical value of these factors is that they can help physicians better identify those patients who may require pharmacological intervention to control itching and pain.</p>","PeriodicalId":11289,"journal":{"name":"Dermatologic Surgery","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Symptoms of Postburn Hypertrophic Scars and Analysis of Risk Factors for Itching and Pain Requiring Pharmacological Intervention.\",\"authors\":\"Bo Chen, Qing Jia, Jing Huang, YaoHui Gu\",\"doi\":\"10.1097/DSS.0000000000004516\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pruritus and pain symptoms secondary to hypertrophic scars (HTSs) are associated with multiple factors, with age, body mass index (BMI), and scar thickness being the main risk factors (RFs).</p><p><strong>Objective: </strong>This study mainly discusses the clinical symptoms associated with postburn HTSs and analyzes RFs for itching and pain requiring pharmacological intervention.</p><p><strong>Materials and methods: </strong>All clinical data of 93 patients with postburn HTSs who visited the Burn Department of Shanghai Seventh People's Hospital between January 1, 2021 and January 1, 2023 were collected and analyzed retrospectively. Referring to the University of North Carolina \\\"4P\\\" Scar Scale, patients were rated as either \\\"with\\\" or \\\"without\\\" according to whether they had \\\"scar itching symptoms requiring pharmacological intervention.\\\"</p><p><strong>Results: </strong>Smoking, third-degree burns, unused silicone drugs, and total burn surface area 30% to 50% were independent RFs for requiring pharmacological intervention for postburn scar pruritus (odds ratio [OR] = 2.998, 3.924, 3.588, and 5.965, p < .05). Age, increased BMI, greater scar thickness, and duration of hyperplasia not more than 1 year significantly increased the risk of scar pain requiring medical intervention (OR = 1.626, 2.441, 20.830, 11.646, and 11.136, p < .05).</p><p><strong>Conclusion: </strong>The clinical value of these factors is that they can help physicians better identify those patients who may require pharmacological intervention to control itching and pain.</p>\",\"PeriodicalId\":11289,\"journal\":{\"name\":\"Dermatologic Surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-12-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dermatologic Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/DSS.0000000000004516\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatologic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/DSS.0000000000004516","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:增生性疤痕(hts)继发的瘙痒和疼痛症状与多种因素相关,年龄、体重指数(BMI)和疤痕厚度是主要的危险因素(RFs)。目的:本研究主要探讨烧伤后HTSs的临床症状,并分析需要药物干预的瘙痒和疼痛的RFs。材料与方法:回顾性分析2021年1月1日至2023年1月1日在上海市第七人民医院烧伤科就诊的93例烧伤后HTSs患者的临床资料。参照北卡罗来纳大学的“4P”疤痕量表,根据患者是否有“需要药物干预的疤痕瘙痒症状”,将患者分为“有”或“没有”。结果:吸烟、三度烧伤、未使用硅酮药物、烧伤总表面积30% ~ 50%是烧伤后瘢痕性瘙痒需要药物干预的独立风险因子(优势比[OR] = 2.998、3.924、3.588、5.965,p < 0.05)。年龄、BMI升高、瘢痕厚度增大以及增生持续时间不超过1年显著增加了需要医疗干预的瘢痕疼痛的风险(OR = 1.626、2.441、20.830、11.646和11.136,p < 0.05)。结论:这些因素的临床价值在于可以帮助医生更好地识别那些可能需要药物干预来控制瘙痒和疼痛的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinical Symptoms of Postburn Hypertrophic Scars and Analysis of Risk Factors for Itching and Pain Requiring Pharmacological Intervention.

Background: Pruritus and pain symptoms secondary to hypertrophic scars (HTSs) are associated with multiple factors, with age, body mass index (BMI), and scar thickness being the main risk factors (RFs).

Objective: This study mainly discusses the clinical symptoms associated with postburn HTSs and analyzes RFs for itching and pain requiring pharmacological intervention.

Materials and methods: All clinical data of 93 patients with postburn HTSs who visited the Burn Department of Shanghai Seventh People's Hospital between January 1, 2021 and January 1, 2023 were collected and analyzed retrospectively. Referring to the University of North Carolina "4P" Scar Scale, patients were rated as either "with" or "without" according to whether they had "scar itching symptoms requiring pharmacological intervention."

Results: Smoking, third-degree burns, unused silicone drugs, and total burn surface area 30% to 50% were independent RFs for requiring pharmacological intervention for postburn scar pruritus (odds ratio [OR] = 2.998, 3.924, 3.588, and 5.965, p < .05). Age, increased BMI, greater scar thickness, and duration of hyperplasia not more than 1 year significantly increased the risk of scar pain requiring medical intervention (OR = 1.626, 2.441, 20.830, 11.646, and 11.136, p < .05).

Conclusion: The clinical value of these factors is that they can help physicians better identify those patients who may require pharmacological intervention to control itching and pain.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Dermatologic Surgery
Dermatologic Surgery 医学-皮肤病学
CiteScore
3.10
自引率
16.70%
发文量
547
期刊介绍: Exclusively devoted to dermatologic surgery, the Dermatologic Surgery journal publishes the most clinically comprehensive and up-to-date information in its field. This unique monthly journal provides today’s most expansive and in-depth coverage of cosmetic and reconstructive skin surgery and skin cancer through peer-reviewed original articles, extensive illustrations, case reports, ongoing features, literature reviews and correspondence. The journal provides information on the latest scientific information for all types of dermatologic surgery including: -Ambulatory phlebectomy- Blepharoplasty- Body contouring- Chemical peels- Cryosurgery- Curettage and desiccation- Dermabrasion- Excision and closure- Flap Surgery- Grafting- Hair restoration surgery- Injectable neuromodulators- Laser surgery- Liposuction- Microdermabrasion- Microlipoinjection- Micropigmentation- Mohs micrographic surgery- Nail surgery- Phlebology- Sclerotherapy- Skin cancer surgery- Skin resurfacing- Soft-tissue fillers. Dermatologists, dermatologic surgeons, plastic surgeons, oculoplastic surgeons and facial plastic surgeons consider this a must-read publication for anyone in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信